Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Opko Biologics

Division of Opko Health Inc.

Latest From Opko Biologics

Pfizer Grows In Rare Disease With $810m Dwarfism Company Buy

Pfizer adds to its rare disease portfolio with purchase of Therachon, a Swiss company working in achondroplasia. But whether it can catch up with Biomarin’s Phase III vosoritide is still to be seen.

Commercial Deals

VELOCITY Failure For Versartis's Lead Drug Sends Shares Into Tailspin

Versartis's long-acting growth hormone product missed Phase III non-inferiority endpoint, wiping more than 83% of the company's value.

Clinical Trials Companies

ADA Curtain-Raiser: CV Data To Steal Show At Diabetes Meeting

In the lead up to 2016's American Diabetes Association (ADA) meeting, to be held June 10-14 in New Orleans, Scrip has handpicked the most exciting data presentations you should check out onsite or catch up with online.

Clinical Trials Metabolic Disorders

Deals In Depth: April 2013

Roche is optioning Isis’ Huntington’s disease antisense candidates in a deal worth $282 million and Thermo Fisher paid just over $15 billion for Life Technologies. Biopharma financing was up 23% to $1.2 billion, device fundraising down 35% to $338 million.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Macromolecule
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Prolor Ltd.
  • Modigene Inc.
  • Prolor Biotech Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Opko Health Inc.
  • Senior Management
  • Abraham Havron, PhD, CEO
    Steve Schaeffer, CFO
  • Contact Info
  • Opko Biologics
    Phone: (972) (866) 644-7811
    Weizmann Science Pk.
    7 Golda Meyer
    Nes Ziona, 74140